Correlation Between Histogen and Artelo Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Histogen and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Histogen and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Histogen and Artelo Biosciences, you can compare the effects of market volatilities on Histogen and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Histogen with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Histogen and Artelo Biosciences.

Diversification Opportunities for Histogen and Artelo Biosciences

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Histogen and Artelo is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Histogen and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Histogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Histogen are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Histogen i.e., Histogen and Artelo Biosciences go up and down completely randomly.

Pair Corralation between Histogen and Artelo Biosciences

Given the investment horizon of 90 days Histogen is expected to generate 59.66 times less return on investment than Artelo Biosciences. But when comparing it to its historical volatility, Histogen is 8.24 times less risky than Artelo Biosciences. It trades about 0.02 of its potential returns per unit of risk. Artelo Biosciences is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  1.02  in Artelo Biosciences on August 25, 2024 and sell it today you would lose (0.46) from holding Artelo Biosciences or give up 45.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy32.8%
ValuesDaily Returns

Histogen  vs.  Artelo Biosciences

 Performance 
       Timeline  
Histogen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Histogen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Artelo Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable essential indicators, Artelo Biosciences is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Histogen and Artelo Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Histogen and Artelo Biosciences

The main advantage of trading using opposite Histogen and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Histogen position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.
The idea behind Histogen and Artelo Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bonds Directory
Find actively traded corporate debentures issued by US companies
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments